NEW BRUNSWICK, N.J.,
Jan. 10, 2019 /PRNewswire/
-- Nominations are now being accepted for the 2019 Dr.
Paul Janssen Award for Biomedical
Research. This prestigious award celebrates today's most dedicated
researchers and champions of science whose basic or clinical
discoveries have made, or have the potential to make, significant
contributions toward improving human health. Nominations will be
accepted until February 28, 2019 at
www.pauljanssenaward.com for consideration by an independent
selection committee of world-renowned scientists. A $200,000 cash prize will be awarded to the
scientist or group of scientists receiving the Award.
The Dr. Paul Janssen Award for
Biomedical Research honors Dr. Paul
Janssen (1926-2003), one of the most productive
pharmaceutical scientists of the 20th century, who was responsible
for breakthrough treatments in key disease areas including pain
management, psychiatry, infectious disease and gastroenterology.
Janssen founded Janssen Pharmaceutica, N.V., now part of the
Johnson & Johnson Family of Companies.
"Behind every discovery that holds the promise for saving and
improving lives are the scientists who pursue a vision and work
tirelessly for many years to make it possible," said Paul Stoffels, M.D., Vice Chairman of the
Executive Committee and Chief Scientific Officer, Johnson &
Johnson. "We are proud to honor the legacy of Dr. Paul by
recognizing the outstanding researchers and champions of science
who make a lasting impact on our world."
In 2018, the Dr. Paul Janssen
Award recognized James Allison,
Ph.D. of the University of Texas MD
Anderson Cancer Center for pioneering a novel and effective
strategy to harness the immune system for treating solid tumor
cancers. Dr. Allison joined 15 other scientists who have received
the Dr. Paul Janssen Award since its
founding in 2004, and he also is the third Dr. Paul Janssen Award recipient who went on to win
the Nobel Prize in the same year.
"Scientific research is crucial to advancing our understanding
of the mechanisms underlying human health and disease," said
David Julius, Ph.D., Professor and
Chair of the Department of Physiology at the University of California, San Francisco, and Chair
of the 2019 Dr. Paul Janssen Award
selection committee. "The selection committee encourages
nominations of scientists from academia, industry, government and
scientific institutions around the world who champion science
through the work they do everyday and exemplify the leadership and
passion of Dr. Paul."
Previous Award winners include:
- 2018 – James Allison, Ph.D.,
Nobel Laureate
- 2017 – Douglas Wallace,
Ph.D.
- 2016 – Yoshinori Ohsumi, Ph.D.,
Nobel Laureate
- 2015 – Bert Vogelstein,
M.D.
- 2014 – Emmanuelle Charpentier,
Ph.D. and Jennifer Doudna,
Ph.D.
- 2013 – David Julius, Ph.D.
- 2012 – Victor Ambros, Ph.D., and
Gary Ruvkun, Ph.D.
- 2011 – Napoleone Ferrara,
M.D.
- 2010 – Anthony S. Fauci, M.D.
and Erik De Clercq, M.D., Ph.D.
- 2009 – Axel Ullrich, Ph.D.
- 2008 – Professor Marc Feldmann,
FMedSci, FAA, FRS, Emeritus Professor and Sir Ravinder Maini, FRCP, FMedSci, FRS
- 2006 – Craig Mello, Ph.D., Nobel
Laureate
To learn more about past Dr. Paul
Janssen Award winners, visit www.pauljanssenaward.com.
The 2019 Dr. Paul Janssen Award
winner will be announced in spring 2019.
About The Dr. Paul Janssen
Award for Biomedical Research
Established by Johnson
& Johnson, The Dr. Paul Janssen
Award salutes champions of science and the most passionate and
creative scientists in basic or clinical research whose scientific
achievements have made, or have strong potential to make, a
measurable impact on human health. The Award is named after the
scientist who founded Janssen Pharmaceutica, N.V. in 1953. Known to
his colleagues as "Dr. Paul," Janssen helped save millions of lives
through his contribution to the discovery and development of more
than 80 medicines, four of which remain on the World Health
Organization's list of essential medicines. In 1961, Janssen
Pharmaceutica, N.V. joined the Johnson & Johnson Family of
Companies. Janssen's legacy continues to inspire Johnson &
Johnson and its commitment to finding innovative cures for unmet
medical needs. Visit www.pauljanssenaward.com for more
information.
About Johnson & Johnson
At Johnson & Johnson (NYSE: JNJ), we believe good health is the
foundation of vibrant lives, thriving communities and forward
progress. That's why for more than 130 years, we have aimed to keep
people well at every age and every stage of life. Today, as the
world's largest and most broadly-based health care company, we are
committed to using our reach and size for good. We strive to
improve access and affordability, create healthier communities, and
put a healthy mind, body and environment within reach of everyone,
everywhere. We are blending our heart, science and ingenuity to
profoundly change the trajectory of health for humanity. To learn
more, visit www.jnj.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/dr-paul-janssen-award-for-biomedical-research-issues-2019-call-for-nominations-to-celebrate-champions-of-science-300776300.html
SOURCE Johnson & Johnson